The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Nanoparticle–aptamer bioconjugates for cancer targeting
Abstract
The combination of targeted drug delivery and controlled-release technology may pave the road for more effective yet safer chemotherapeutic options for cancer therapy. Drug-encapsulated polymeric nanoparticle-aptamer bioconjugates represent an emerging technology that can facilitate the delivery of chemotherapeutics to primary and metastatic tumours. Aptamers are short nucleic acid molecules with binding properties and biochemical characteristics that may make them suitable for use as targeting molecules. The goal of this review is to summarise the key components that are required for creating effective cancer targeting nanoparticle-aptamer bioconjugates. The field of controlled release and the structure and properties of aptamers, as well as the criteria for constructing effective conjugates, will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection
Chan, W. C. W., & Nie, S. (1998) · Science · doi:10.1126/science.281.5385.2016 · Cited by 7,278
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · cited 2×
“This phenomenon has been exploited to target various forms of nanoparticles, quantum dots, liposomes and drug–ligand conjugates to cancer tissue for therapeutic and diagnostic applications (reviewed by Maeda [73]).”
BackgroundCancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558 · cited 2×
“With the advances in nanotechnology, it is now possible to combine specialised delivery vehicles and targeting approaches to develop highly selective and effective therapeutic and diagnostic modalities that may improve the outcome for a myriad of important diseases, including cancers [1,2].”
BackgroundBiodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Designing materials for biology and medicine
Langer, R., & Tirrell, D. A. (2004) · Nature · doi:10.1038/nature02388 · Cited by 3,198 · cited 2×
“With the advances in nanotechnology, it is now possible to combine specialised delivery vehicles and targeting approaches to develop highly selective and effective therapeutic and diagnostic modalities that may improve the outcome for a myriad of important diseases, including cancers [1,2].”
BackgroundSelf-citationNanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Self-citationMaeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Biodegradable, Elastic Shape-Memory Polymers for Potential Biomedical Applications
Lendlein, A., & Langer, R. (2002) · Science · doi:10.1126/science.1066102 · Cited by 2,146
Self-citation(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029 · cited 1×
“It is important to note that a detailed review is beyond the scope of this manuscript and the reader is referred to the following reviews for further information [68-72].”
BackgroundLight-induced shape-memory polymers
Lendlein, A., Jiang, H., Jünger, O., & Langer, R. (2005) · Nature · doi:10.1038/nature03496 · Cited by 2,006 · cited 1×
“Controlled release of drugs that are encapsulated within a material is achieved by the release of encapsulated drugs through surface or bulk erosion, diffusion, or swelling followed by diffusion or triggered by the environment or other external events [2] such as changes in pH [63], light [64], temperature [65] or the…”
BackgroundSelf-citationNoninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Adaptive Recognition by Nucleic Acid Aptamers
Hermann, T., & Patel, D. J. (2000) · Science · doi:10.1126/science.287.5454.820 · Cited by 1,650
Small-scale systems for in vivo drug delivery
LaVan, D. A., McGuire, T., & Langer, R. (2003) · Nature Biotechnology · doi:10.1038/nbt876 · Cited by 1,304
Self-citationIn Vitro Selection of Functional Nucleic Acids
Wilson, D. S., & Szostak, J. W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.611 · Cited by 1,206
High-Resolution Molecular Discrimination by RNA
Jenison, R. D., Gill, S. C., Pardi, A., & Polisky, B. (1994) · Science · doi:10.1126/science.7510417 · Cited by 1,188
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,174
Self-citationAnalytical applications of aptamers
Tombelli, S., Minunni, M., & Mascini, M. (2005) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2004.11.006 · Cited by 1,017
Advances in biomaterials, drug delivery, and bionanotechnology
Langer, R., & Peppas, N. A. (2003) · AIChE Journal · doi:10.1002/aic.690491202 · Cited by 966
Self-citationYuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., & Jain, R. K. (1994) · PubMed · Cited by 908
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules
Weissleder, R., Kelly, K., Sun, E. Y., Shtatland, T., & Josephson, L. (2005) · Nature Biotechnology · doi:10.1038/nbt1159 · Cited by 904
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Self-citationA controlled-release microchip
Santini, J. T., Cima, M. J., & Langer, R. (1999) · Nature · doi:10.1038/16898 · Cited by 868
Self-citationPLGA Nanoparticles in Drug Delivery: The State of the Art;
Bala, I., Hariharan, S., & Kumar, M. R. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i5.20 · Cited by 739
Scaling down imaging: molecular mapping of cancer in mice
Weissleder, R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc701 · Cited by 708
Bilati, U., Allémann, E., & Doelker, E. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.09.011 · Cited by 686
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.
Kong, G., Braun, R. D., & Dewhirst, M. W. (2000) · PubMed · Cited by 633
Langer, R. (2001) · Science · doi:10.1126/science.1063273 · Cited by 579
Self-citationLupold, S. E., Hicke, B. J., Lin, Y. H., & Coffey, D. S. (2002) · PubMed · Cited by 566
Characterization of nanoparticle uptake by endothelial cells
Davda, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00923-1 · Cited by 524
Bander, N. H., Milowsky, M. I., Nanus, D. M., Kostakoglu, L., Vallabhajosula, S., & Goldsmith, S. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.160 · Cited by 509
Polysaccharide-decorated nanoparticles
Lemarchand, C., Gref, R., & Couvreur, P. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.02.016 · Cited by 500
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels
Christian, S., Pilch, J., Akerman, M. E., Porkka, K., Laakkonen, P., & Ruoslahti, E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304132 · Cited by 497
JIANG, W., GUPTA, R., DESHPANDE, M., & SCHWENDEMAN, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.003 · Cited by 478
Liu, D., Mori, A., & Huang, L. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90136-a · Cited by 463
Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes
Pieken, W. A., Olsen, D. B., Benseler, F., Aurup, H., & Eckstein, F. (1991) · Science · doi:10.1126/science.1857967 · Cited by 463
Pietras, K., Östman, A., SJÖQUIST, M., Buchdunger, E., Reed, R. K., Heldin, C., & Rubin, K. (2001) · PubMed · Cited by 450
Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication
Sullenger, B. A., Gallardo, H. F., Ungers, G. E., & Gilboa, E. (1990) · Cell · doi:10.1016/0092-8674(90)90455-n · Cited by 443
Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.
Pietras, K., Rubin, K., Sjöblom, T., Buchdunger, E., Sjöquist, M., Heldin, C., & Östman, A. (2002) · PubMed · Cited by 433
Biophysical and biological properties of quadruplex oligodeoxyribonucleotides
Dapic, V. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg316 · Cited by 397
Campbell, R. B., Fukumura, D., Brown, E. B., Mazzola, L. M., Izumi, Y., Jain, R. K., Torchilin, V. P., & Munn, L. L. (2002) · PubMed · Cited by 372
Bonnemain, B. (1998) · Journal of Drug Targeting · doi:10.3109/10611869808997890 · Cited by 371
Chorny, M., Fishbein, I., Danenberg, H. D., & Golomb, G. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00211-0 · Cited by 370
Transport of fluid and macromolecules in tumors
Baxter, L. T., & Jain, R. K. (1991) · Microvascular Research · doi:10.1016/0026-2862(91)90003-t · Cited by 368
Monsky, W. L., Fukumura, D., Gohongi, T., Ancukiewcz, M., Weich, H. A., Torchilin, V. P., Yuan, F., & Jain, R. K. (1999) · PubMed · Cited by 368
Chonn, A., Cullis, P. R., & Devine, D. V. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.12.4234 · Cited by 367
Microparticle formation and its mechanism in single and double emulsion solvent evaporation
Rosca, I. D., Watari, F., & Uo, M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.007 · Cited by 364
Direct In Vitro Selection of a 2′-O-Methyl Aptamer to VEGF
Burmeister, P. E., Lewis, S. D., Silva, R. F., Preiss, J. R., Horwitz, L. R., Pendergrast, P. S., McCauley, T. G., Kurz, J. C., Epstein, D. M., Wilson, C., et al. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.10.017 · Cited by 347
A Method for the High Efficiency of Water-Soluble Carbodiimide-Mediated Amidation
Sehgal, D., & Vijay, I. K. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1144 · Cited by 345
Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels
Blank, M., Weinschenk, T., Priemer, M., & Schluesener, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100347200 · Cited by 326
Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein
Hicke, B. J., Marion, C., Chang, Y.-F., Gould, T., Lynott, C. K., Parma, D., Schmidt, P. G., & Warren, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104651200 · Cited by 324
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems
Alonso, M. J., Gupta, R. K., Min, C., Siber, G. R., & Langer, R. (1994) · Vaccine · doi:10.1016/0264-410x(94)90092-2 · Cited by 313
Self-citationPharmacokinetics and Biodistribution of Novel Aptamer Compositions
Healy, J. M., Lewis, S. D., Kurz, M., Boomer, R. M., Thompson, K. M., Wilson, C., & McCauley, T. G. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7676-4 · Cited by 298
Elisseeff, J., McIntosh, W., Fu, K., Blunk, T., & Langer, R. (2001) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(01)00054-7 · Cited by 296
Self-citationDeveloping aptamers into therapeutics
White, R. R., Sullenger, B. A., & Rusconi, C. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11325 · Cited by 295
Mosqueira, V. C. F., Legrand, P., Morgat, J.-L., Vert, M., Mysiakine, E., Gref, R., Devissaguet, J.-P., & Barratt, G. (2001) · Pharmaceutical Research · doi:10.1023/a:1012248721523 · Cited by 289
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function
Schmidt, K. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh862 · Cited by 287
A polymer library approach to suicide gene therapy for cancer
Anderson, D. G., Peng, W., Akinc, A., Hossain, N., Kohn, A., Padera, R., Langer, R., & Sawicki, J. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407218101 · Cited by 258
Self-citationLynn, D. M., Amiji, M. M., & Langer, R. (2001) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20010504)40:9<1707::aid-anie17070>3.0.co;2-f · Cited by 256
Self-citationChemical Modification of Hammerhead Ribozymes
Beigelman, L., McSwiggen, J. A., Draper, K. G., Gonzalez, C., Jensen, K., Karpeisky, A. M., Modak, A. S., Matulic-Adamic, J., DiRenzo, A. B., Haeberli, P., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25702 · Cited by 229
Her-2/neu Overexpression and Amplification in Uterine Papillary Serous Carcinoma
Slomovitz, B. M., Broaddus, R. R., Burke, T. W., Sneige, N., Soliman, P. T., Wu, W., Sun, C. C., Munsell, M. F., Gershenson, D. M., & Lu, K. H. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.154 · Cited by 219
Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity.
Santulli-Marotto, S., Nair, S. K., Rusconi, C. P., Sullenger, B. A., & Gilboa, E. (2003) · PubMed · Cited by 214
Controlled drug release from hydrogel nanoparticle networks
Huang, G., Gao, J., Hu, Z., St. John, J. V., Ponder, B. C., & Moro, D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.10.007 · Cited by 207
Drolet, D. W., Nelson, J., Tucker, C. E., Zack, P. M., Nixon, K., Bolin, R., Judkins, M. B., Farmer, J. A., Wolf, J. L., Gill, S. C., et al. (2000) · Pharmaceutical Research · doi:10.1023/a:1007657109012 · Cited by 206
Human Antibody Fragments Specific for Human Blood Group Antigens from a Phage Display Library
Marks, J. D., Ouwehand, W. H., Bye, J. M., Finnern, R., Gorick, B. D., Voak, D., Thorpe, S., Hughes-Jones, N. C., & Winter, G. (1993) · Nature Biotechnology · doi:10.1038/nbt1093-1145 · Cited by 202
Influence of polysaccharide coating on the interactions of nanoparticles with biological systems
Lemarchand, C., Gref, R., Passirani, C., Garcion, E., Petri, B., Müller, R., Costantini, D., & Couvreur, P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.04.041 · Cited by 196
Applications of Liposomes in Ophthalmology
Ebrahim, S., Peyman, G. A., & Lee, P. J. (2005) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2004.12.006 · Cited by 193
Chen, C.-H. B., Chernis, G. A., Hoang, V. Q., & Landgraf, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332660100 · Cited by 190
Aptamers against extracellular targets for in vivo applications
Pestourie, C., Tavitian, B., & Duconge, F. (2005) · Biochimie · doi:10.1016/j.biochi.2005.04.013 · Cited by 183
Spiegelmers: Biostable Aptamers
Eulberg, D., & Klussmann, S. (2003) · ChemBioChem · doi:10.1002/cbic.200300663 · Cited by 181
Biomimetic polymers in pharmaceutical and biomedical sciences
Drotleff, S., Lungwitz, U., Breunig, M., Dennis, A., Blunk, T., Tessmar, J., & Göpferich, A. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.018 · Cited by 174
Microfluidic System for Studying the Interaction of Nanoparticles and Microparticles with Cells
Farokhzad, O. C., Khademhosseini, A., Jon, S., Hermmann, A., Cheng, J., Chin, C., Kiselyuk, A., Teply, B., Eng, G., & Langer, R. (2005) · Analytical Chemistry · doi:10.1021/ac050312q · Cited by 174
Self-citationFitzwater, T., & Polisky, B. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)67019-0 · Cited by 172
Bilati, U., Allémann, É., & Doelker, É. (2005) · Journal of Microencapsulation · doi:10.1080/02652040400026442 · Cited by 172
Escort aptamers: a delivery service for diagnosis and therapy
Hicke, B. J., & Stephens, A. W. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11324 · Cited by 169
Evolution of a T7 RNA polymerase variant that transcribes 2′-O-methyl RNA
Chelliserrykattil, J., & Ellington, A. D. (2004) · Nature Biotechnology · doi:10.1038/nbt1001 · Cited by 168
In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase
Charlton, J., Sennello, J., & Smith, D. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90114-9 · Cited by 163
Recent Advances in Brain Tumor Therapy: Local Intracerebral Drug Delivery by Polymers
Guérin, C. J., Olivi, A., WEINGART, J. D., Lawson, H. C., & Brem, H. (2003) · Investigational New Drugs · doi:10.1023/b:drug.0000006172.65135.3e · Cited by 153
Layer-by-Layer Surface Modification and Patterned Electrostatic Deposition of Quantum Dots
Jaffar, S., Nam, K. T., Khademhosseini, A., Xing, J., Langer, R., & Belcher, A. M. (2004) · Nano Letters · doi:10.1021/nl0493287 · Cited by 146
Self-citation2'-Fluoro and 2-amino-2'-deoxynucleoside 5'-triphosphates as substrates for T7 RNA polymerase
Aurup, H., Williams, D. M., & Eckstein, F. (1992) · Biochemistry · doi:10.1021/bi00155a016 · Cited by 137
DAB389IL-2 (ONTAK): A Novel Fusion Toxin Therapy for Lymphoma
Foss, F. M. (2000) · Clinical Lymphoma · doi:10.3816/clm.2000.n.009 · Cited by 126
Matsusue, Y., Hanafusa, S., Yamamuro, T., Shikinami, Y., & Ikada, Y. (1995) · PubMed · Cited by 122
Pakalapati, L. V. V. (2003) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 99
Increased bone marrow toxicity of doxorubicin bound to nanoparticles
Gibaud, S., Andreux, J. P., Weingarten, C., Renard, M., & Couvreur, P. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90299-2 · Cited by 94
Nanoparticle-mediated gene delivery: state of the art
Kumar, M., Hellermann, G., Lockey, R. F., & Mohapatra, S. S. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.8.1213 · Cited by 93
Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration
Doggrell, S. A. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.8.1421 · Cited by 90
Takahira, N., Itoman, M., Higashi, K., Uchiyama, K., Miyabe, M., & Naruse, K. (2003) · Journal of Orthopaedic Science · doi:10.1007/s007760300004 · Cited by 89
Internalization of anti-nucleolin antibody into viable HEp-2 cells
Deng, J., Ballou, B. T., & Hofmeister, J. K. (1996) · Molecular Biology Reports · doi:10.1007/bf00351168 · Cited by 73
Jeong-Yu, S., Eom, T.-Y., Kim, S.-J., Lee, S., & Yu, J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4327 · Cited by 70
Poly(ethyleneglycol)-Coated Nanospheres: Potential Carriers for Intravenous Drug Administration
Gref, R., Minamitake, Y., Peracchia, M. T., Domb, A. J., Trubetskoy, V. S., Torchilin, V. P., & Langer, R. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46803-4_6 · Cited by 66
Self-citationSplenic Trapping of Nanoparticles: Complementary Approaches for In Situ Studies
Demoy, M., Gibaud, S., Andreux, J. P., Weingarten, C., Gouritin, B., & Couvreur, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012095431931 · Cited by 62
Lode, J., Fichtner, I., Kreuter, J., Berndt, A., Diederichs, J. E., & Reszka, R. C. (2001) · Pharmaceutical Research · doi:10.1023/a:1013094801351 · Cited by 47
Local Drug Delivery Using Coated Stents: New Developments and Future Perspectives
Tanabe, K., Regar, E. S., Lee, C., Hoye, A., van der Giessen, W. J., & Serruys, P. W. J. C. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453289 · Cited by 38
Update on the first phase I study of AGRO100 in advanced cancer
Laber, D. A., Sharma, V. R., Bhupalam, L., Taft, B. S., Hendler, F. J., & Barnhart, K. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.3064 · Cited by 36
Androgen-Independent Prostate Cancer
Schrijvers, D. L. A. L. (2007) · Springer eBooks · doi:10.1007/978-3-540-40901-4_14 · Cited by 31
Surface Modification of Polyanhydride Microspheres
Gao, J., Niklason, L. E., Zhao, X., & Langer, R. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970284u · Cited by 26
Self-citationLong-term stability of PBCA nanoparticle suspensions
P. Sommerfeld, B. A. S. (2000) · Journal of Microencapsulation · doi:10.1080/026520400288562 · Cited by 25
Selection of Internalizing Antibodies for Drug Delivery
Marks, J. D. (2004) · Humana Press eBooks · doi:10.1385/1-59259-666-5:201 · Cited by 14
AGRO100: The translation from lab to clinic of a tumor-targeted nucleic acid aptamer
Barnhart, K. M., Laber, D. A., Bates, P. J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.3126 · Cited by 7
Cited by
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Self-citationEngineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Nanomedicine—Challenge and Perspectives
Riehemann, K., Schneider, S. W., Luger, T. A., Godin, B., Ferrari, M., & Fuchs, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802585 · Cited by 1,305
Metadata
- Authors
- Farokhzad, O. C., Karp, J. M., & Langer, R.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2006-04-26
- Volume
- 3
- Issue
- 3
- Pages
- 311-324
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2165299361
- Cited by
- 256
- References
- 105
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.